Cargando…
CAR T cells: engineered immune cells to treat brain cancers and beyond
Malignant brain tumors rank among the most challenging type of malignancies to manage. The current treatment protocol commonly entails surgery followed by radiotherapy and/or chemotherapy, however, the median patient survival rate is poor. Recent developments in immunotherapy for a variety of tumor...
Autores principales: | Huang, Zoufang, Dewanjee, Saikat, Chakraborty, Pratik, Jha, Niraj Kumar, Dey, Abhijit, Gangopadhyay, Moumita, Chen, Xuan-Yu, Wang, Jian, Jha, Saurabh Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890802/ https://www.ncbi.nlm.nih.gov/pubmed/36721153 http://dx.doi.org/10.1186/s12943-022-01712-8 |
Ejemplares similares
-
Molecular Mechanism and Role of Japanese Encephalitis Virus Infection in Central Nervous System-Mediated Diseases
por: Yadav, Pardeep, et al.
Publicado: (2022) -
Antioxidants in brain tumors: current therapeutic significance and future prospects
por: Qi, Xuchen, et al.
Publicado: (2022) -
Molecular basis of fluoride toxicities: Beyond benefits and implications in human disorders
por: Pal, Priyankar, et al.
Publicado: (2022) -
Nanomedicines for the management of diabetic nephropathy: present progress and prospects
por: Paul, Paramita, et al.
Publicado: (2023) -
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
por: Ye, Feng, et al.
Publicado: (2023)